The mission of Sampling Human is to couple health related decisions to their effects at the single cell level. It is inspired by the founders’ academic and professional efforts to extend what is measurable and to derive what must be measured. The human body is a complex system that cannot be quantified exhaustively or heuristically. Clinical diagnosis today is an imprecise art. On average, diagnosis of rare diseases is 5 years delayed with 50% of delays impacting the outcome. Misdiagnosis is far too common with a 66% likelihood of disagreement between experts. We are stuck with symptoms based medicine. The nature of physiological data is to blame. Decisions today are based on fuzzy variables (tired, drowsy, weak, tingling, itchy, etc). Better decisions will require precise knowledge regarding the fundamental physiological units of our bodies, CELLS.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $2M
Founded date: 2016
Investors 1
| Date | Name | Website |
| 30.10.2023 | Formic Ven... | formic.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.04.2022 | Seed | $2M | - |
Mentions in press and media 1
| Date | Title | Description |
| 18.04.2022 | Sampling Human Raises $2M in Funding | Sampling Human, a San Diego, CA-based early stage, life science technology company that has developed a diagnostic platform that harnesses genetically engineered cells to analyze other cells in their environment, raised $2m in funding. The ... |